![Annie Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Annie Li
Fondateur chez Mizzen Capital Management LLC
Postes actifs de Annie Li
Sociétés | Poste | Début | Fin |
---|---|---|---|
Mizzen Capital Management LLC | Fondateur | 01/03/2019 | - |
Private Equity Investor | 01/03/2019 | - |
Historique de carrière de Annie Li
Anciens postes connus de Annie Li
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sunrise Equity Partners
![]() Sunrise Equity Partners Investment ManagersFinance Sunrise Equity Partners is a private equity firm founded in 2003 by Marilyn Adler, Nathan Low, and Amnon Mandelbaum. The firm is headquartered in New York. | Analyste en capital-investissement | 01/04/2007 | 30/04/2013 |
Rodman & Renshaw LLC (Old)
![]() Rodman & Renshaw LLC (Old) Investment Banks/BrokersFinance Founded in 2003 by Cliff Rodman and Charles Renshaw, Rodman & Renshaw LLC is a full-service investment bank and broker/dealer located in New York City with an additional office in Boston. The firm is a subsidiary of Rodman & Renshaw Capital Group (NasdaqGM: RODM). The firm provides corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. They also provide research and sales and trading services to institutional investors. Rodman & Renshaw is a leader in the PIPE and RD (registered direct offering) transaction markets. The firm's research focuses on Asia, clean technology, community & regional banks, energy, industrial and commercial services, life science/healthcare and metals and mining. Rodman & Renshaw is a member of the NASD and the SIPC. | Analyst-Equity | - | 31/12/2006 |
IntraBiotics Pharmaceuticals, Inc.
![]() IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Corporate Officer/Principal | 01/01/1999 | - |
Formation de Annie Li
China Agricultural University | Undergraduate Degree |
University of Florida | Graduate Degree |
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Columbia Business School | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 8 |
Chine | 2 |
Opérationnelle
Masters Business Admin | 2 |
Analyst-Equity | 1 |
Private Equity Analyst | 1 |
Sectorielle
Consumer Services | 5 |
Finance | 4 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Rodman & Renshaw LLC (Old)
![]() Rodman & Renshaw LLC (Old) Investment Banks/BrokersFinance Founded in 2003 by Cliff Rodman and Charles Renshaw, Rodman & Renshaw LLC is a full-service investment bank and broker/dealer located in New York City with an additional office in Boston. The firm is a subsidiary of Rodman & Renshaw Capital Group (NasdaqGM: RODM). The firm provides corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. They also provide research and sales and trading services to institutional investors. Rodman & Renshaw is a leader in the PIPE and RD (registered direct offering) transaction markets. The firm's research focuses on Asia, clean technology, community & regional banks, energy, industrial and commercial services, life science/healthcare and metals and mining. Rodman & Renshaw is a member of the NASD and the SIPC. | Finance |
Sunrise Equity Partners
![]() Sunrise Equity Partners Investment ManagersFinance Sunrise Equity Partners is a private equity firm founded in 2003 by Marilyn Adler, Nathan Low, and Amnon Mandelbaum. The firm is headquartered in New York. | Finance |
IntraBiotics Pharmaceuticals, Inc.
![]() IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Mizzen Capital Management LLC | Finance |